Refine
Year of publication
- 2014 (2799) (remove)
Document Type
- Article (1080)
- Part of Periodical (372)
- Book (269)
- Working Paper (213)
- Contribution to a Periodical (173)
- Doctoral Thesis (168)
- Report (148)
- Review (146)
- Part of a Book (83)
- Conference Proceeding (51)
Language
- German (1402)
- English (1234)
- Croatian (70)
- Portuguese (28)
- French (19)
- Turkish (12)
- Multiple languages (11)
- Spanish (7)
- Danish (3)
- Bosnian (2)
Keywords
- Deutsch (38)
- Literatur (35)
- Rilke, Rainer Maria (35)
- Ukraine (24)
- USA (22)
- taxonomy (22)
- Deutschland (21)
- Russland (21)
- Benjamin, Walter (19)
- new species (19)
Institute
- Präsidium (355)
- Medizin (274)
- Gesellschaftswissenschaften (204)
- Wirtschaftswissenschaften (182)
- Center for Financial Studies (CFS) (146)
- Physik (134)
- Sustainable Architecture for Finance in Europe (SAFE) (101)
- Biowissenschaften (99)
- House of Finance (HoF) (99)
- Exzellenzcluster Die Herausbildung normativer Ordnungen (86)
In den Bergwäldern der Bayerischen Alpen sind Standorte mit geringer Nachlieferung von N, P und K, z. T. auch von Mg und Ca weit verbreitet. Um diese gegenüber Biomassenutzung empfindlichen Standorte im Gelände zu erkennen, können Pflanzenarten der Bodenvegetation als Indikatoren genutzt werden. Ziel unserer Arbeit war es, anhand einer umfangreichen Vegetations- und Bodendatenbank Indikatorarten für nährstoffarme Waldstandorte in den Bayerischen Alpen zu ermitteln. Mit Hilfe einer Indikatorartenanalyse wurden insgesamt 745 verschiedene Gefäßpflanzenarten und die Torfmoose (auf Gattungsebene zusammengefasst) auf ihre Eignung als Indikatorarten überprüft. Dazu wurden insgesamt 1.496 durch Vegetationsaufnahmen und Bodenprofilansprachen gekennzeichnete Waldstandorte hinsichtlich ihrer Nährstoffversorgung eingestuft und ausgewertet. Potentilla erecta, Vaccinium vitis-idaea, Homogyne alpina und Huperzia selago wurden als allgemeine Indikatorarten für nährstoffarme Standorte ermittelt. Vorkommen von Vaccinium myrtillus (Deckung ≥ 5 %) sowie Vorkommen von Juncus effusus, Luzula sylvatica und Luzula pilosa weisen auf nährstoffarme, tiefgründig versauerte Mineralböden mit Auflagehumus hin, während Calamagrostis varia, Sesleria albicans, Melampyrum sylvaticum, Aster bellidiastrum und Anthoxanthum odoratum eng an nährstoffarme kalkreiche Standorte gebunden sind. Die dargestellten Indikatorarten wurden speziell für die nährstoffarmen Waldstandorte der Bayerischen Alpen zusammengestellt. Sie ermöglichen ohne viel Sach- und Zeitaufwand im Gelände eine Ansprache von nährstoffarmen Waldstandorten, deren Nährstoffangebot aus Standortskarten nur grob eingeschätzt werden kann.
Ziel: Die Vegetation der mitteleuropäischen Buchenwälder hat sich in den vergangenen Jahrzehnten deutlich verändert. Über die Änderungen in den wärmeliebenden Seggen-Hangbuchenwäldern (Carici-Fagetum) unter dem Einfluss des Nutzungs- und Klimawandels, der Eutrophierung und des Schalenwild-Einflusses ist aber bisher wenig bekannt. Wir verglichen Vegetationsaufnahmen des Carici-Fagetum aus den 1950er Jahren mit aktuellen und fragten: (1) Wie haben sich Struktur, Diversität und Artenzusammensetzung verändert? (2) Was sind die treibenden Faktoren dieser Veränderungen? (3) Welche Rückschlüsse ergeben sich für die zukünftige Entwicklung und Behandlung dieser Wälder?
Untersuchungsgebiet: Göttinger Wald (Süd-Niedersachsen, Deutschland, Mitteleuropa)
Methoden: Die Vegetation von 78 Quasi-Dauerflächen in vier Subassoziationen des Carici-Fagetum wurde im Zeitraum 1955 bis 1960 und 2011 bis 2012 aufgenommen. Unterschiede in der Vegetationsstruktur, der Diversität und Artenzusammensetzung sowie hinsichtlich verschiedener forstlicher und standortökologischer Parameter und ökologischer Artengruppen zwischen beiden Aufnahmeterminen wurden mit Hilfe von Ordinations- und Permutations-Verfahren sowie paarweiser Vergleiche analysiert und statistisch geprüft.
Ergebnisse: Strukturell hat vor allem die Strauchschicht stark zugenommen, insbesondere bedingt durch eine Intensivierung der Rehwild-Bejagung. In der Bodenvegetation haben die typischen Arten des Carici-Fagetum stark abgenommen, darunter auch viele Rote-Liste-Arten. Zugenommen haben dagegen neben den Gehölzen die weit verbreiteten Arten der mesophilen Buchenwälder. Dies zeigt sich auch in den Veränderungen der Zeigerwerte nach Ellenberg. Dem Rückgang von lichtliebenden, trockenheitsertragenden Magerkeitszeigern steht eine Zunahme von schattentoleranten, mesophilen und an eine bessere Nährstoffversorgung gebundenen Arten der geschlossenen Buchenwälder gegenüber, was zu einer zunehmenden Homogenisierung der Vegetation führt. Ursachen für diese Veränderungen sind das geänderte Bestandesklima durch eine dichter schließende Strauchschicht und atmosphärische Stickstoffeinträge, wobei letzteres wohl vor allem das Wachstum der Buche förderte. Eine deutliche Zunahme des immergrünen, ozeanisch verbreiteten Efeu (Hedera helix), der sehr empfindlich auf tiefe Temperaturen im Winter reagiert, gleichzeitig aber bei erhöhtem CO2-Angebot seine Wuchsleistung über proportional erhöht, kann als Reaktion auf den Klimawandel der letzten 50 Jahre gewertet werden. Positiv hat sich auch eine Reduktion des Rehwild-Verbisses auf diese und andere Arten – z. B. Lilium martagon als einzige Rote-Liste-Art mit einer positiven Deckungsgradentwicklung – ausgewirkt.
Schlussfolgerungen: Die wärmeliebenden Seggen-Hangbuchenwälder haben in den letzten 50 Jahren charakteristische und wertvolle floristische Elemente – häufig Relikte der früheren Mittelwaldnutzung in Verbindung mit Waldweide – verloren. Mit der Einstellung der forstlichen Nutzung, z. T. bedingt durch Naturschutzmaßnahmen, der Reduktion des Schalenwildverbisses und den atmosphärischen Nährstoffeinträgen zeigt das Carici-Fagetum im Göttinger Wald heute eine Sukzession zum mesophilen Wald, wie sie für viele thermophile Laubwälder in Mitteleuropa nach Jahrhunderten der Auflichtung und Aushagerung typisch geworden ist.
The endemic Floridian milliped genus, Floridobolus Causey, 1957, more closely related to tylobolinines in the western United States (US), Mexico, and Guatemala than syntopic spirobolines, is incorporated into Spirobolidae (Spirobolida: Spirobolidea). With taxonomic priority by one year, its monotypic family is reduced to Floridobolinae, n. stat., comprising Floridobolini and Tylobolini, n. stats., the counterpart to Spirobolinae, comprising Spirobolini and Aztecolini, n. tribe; relationships are Floridobolini + (Tylobolini + (Aztecolini + Spirobolini)). Like F. penneri Causey, 1957, 208 km (130 mi) to the south in the Lake Wales Ridge, Polk and Highlands counties (cos.), F. orini n. sp., inhabits “Big Scrub” environments in the Ocala National Forest, Marion Co. Biogeographic reconstructions, compatible with broader hypotheses on the class’ evolutionary history, indicate that, from a presumptive source area in northern Mexico where the subfamilies overlap, spirobolid stock penetrated the “proto-US” four times, once per tribe, before the Western Interior Seaway developed in the Cretaceous Period, Mesozoic Era. Three expansions headed northeastward into future “Appalachia,” from which taxa spread southward as the Seaway receded. Floridobolini, the fi rst invader, had to be in “proto-Georgia” and positioned to penetrate Florida when the sand dunes that comprise the “Central Highlands” emerged from the sea in the Oligocene (Cenozoic), ~25 mya. As sea levels rose and fell, the dunes fragmented into islands and the subcontinuous Floridobolus population was partitioned. The southernmost became F. penneri; F. orini inhabited a northern island; and a graduate student is investigating other insular remnants for additional species. Shortly after Floridobolini began spreading, Hiltonius/ Tylobolini arose and expanded both southward to Guatemala and northwestward to California; Tylobolus Cook, 1904, diverged in the latter area and dispersed northward to Washington and eastward to Utah/Arizona. The third invader, and the second to disperse northeastward, was Aztecolini, which probably eradicated Floridobolini from some of its established range and was partitioned into Mexican (Aztecolus Chamberlin, 1943) and US (Chicobolus Chamberlin, 1947) taxa by the Seaway. The fi nal invader, Spirobolini, dispersed northwestward and northeastward to both the Pacifi c and Atlantic coasts; instead of Trans-Beringia, we prefer penetration of the Asian part of “Asiamerica,” when it temporarily formed during the Cretaceous, to explain the Mongolian fossil genus, Gobiulus Dzik, 1975, herein assigned to Tylobolini, and the occurrence of Spirobolus Brandt, 1833, in China and Taiwan today. In the east, Narceus Rafi nesque, 1820, spread across Appalachia, eradicated most remaining populations of Floridobolus and Chicobolus, and expanded to Maine and Québec after retreat of the Wisconsin glaciation. Chicobolus and Narceus also penetrated earliest Florida; the former established itself in the Central Highlands, spread through the widening peninsula as sea levels fell, and remained on insular refugia when waters rose. Apparently fueled by the different Floridian environments, Narceus underwent time-consuming speciation; consequently, Floridobolus and Chicobolus still survive on the peninsula, and an allopatric population of the latter inhabits coastal South Carolina. However, N. gordanus (Chamberlin, 1943) occurs syntopically with both in peninsular Florida and may be actively eradicating them from their last stronghold. Trigoniulus niger, takahasii, and segmentatus, all by Takakuwa, 1940, are removed from Spirobolidae and returned toTrigoniulidae (Trigoniulidea). New records in the Appendix include the fi rst of Aztecolus from Durango and Jalisco, Mexico.
Aufgrund von § 44 Abs. 1 Nr. 1 des Hessischen Hochschulgesetzes vom 14. Dezember 2009 (GVBl. I S. 666), zuletzt geändert durch Gesetz vom 27. Mai 2013 (GVBl. S. 218), hat der Fachbereichsrat des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt am Main am 3. Juli 2014 die nachstehende Ordnung erlassen:...
Aufgrund der §§ 20, 44 Abs. 1 Nr. 1 des Hessischen Hochschulgesetztes in der Fassung vom 14. Dezember 2009, zu-letzt geändert durch Gesetz vom 27. Mai 2013, hat der Fachbereichsrat des Fachbereichs Wirtschaftswissenschaften der Johann Wolfgang Goethe-Universität Frankfurt am Main am 16.07.2014 die folgende Ordnung für den Master-studiengang Wirtschaftspädagogik beschlossen. Diese Ordnung hat das Präsidium der Johann Wolfgang Goethe-Universität gemäß § 37 Abs. 5 Hessisches Hochschulgesetz am 5. August 2014 genehmigt. Sie wird hiermit bekannt gegeben.
Background: Unlike metastatic colorectal cancer (CRC) there are to date few reports concerning the predictive value of molecular biomarkers on the clinical outcome in stage II/III CRC patients receiving adjuvant chemotherapy. Aim of this study was to assess the predictive value of proteins related with the EGFR- and VEGFR- signalling cascades in these patients.
Methods: The patients' data examined in this study were from the collective of the 5-FU/FA versus 5-FU/FA/irinotecan phase III FOGT-4 trial. Tumor tissues were stained by immunohistochemistry for VEGF-C, VEGF-D, VEGFR-3, Hif-1 α, PTEN, AREG and EREG expression and evaluated by two independent, blinded investigators. Survival analyses were calculated for all patients receiving adjuvant chemotherapy in relation to expression of all makers above.
Results: Patients with negative AREG and EREG expression on their tumor had a significant longer DFS in comparison to AREG/EREG positive ones (p< 0.05). The benefit on DFS in AREG-/EREG- patients was even stronger in the group that received 5-FU/FA/irinotecan as adjuvant treatment (p=0.002). Patients with strong expression of PTEN profited more in terms of OS under adjuvant treatment containing irinotecan (p< 0.05). Regarding markers of the VEGFR- pathway we found no correlation of VEGF-C- and VEGFR-3 expression with clinical outcome. Patients with negative VEGF-D expression had a trend to live longer when treated with 5-FU/FA (p=0.106). Patients who were negative for Hif-1 α, were disease-free in more than 50% at the end of the study and showed significant longer DFS-rates than those positive for Hif-1 α (p=0.007). This benefit was even stronger at the group treated with 5-FU/FA/irinotecan (p=0.026). Finally, AREG-/EREG-/PTEN+ patients showed a trend to live longer under combined treatment combination.
Conclusions: The addition of irinotecan to adjuvant treatment with 5-FU/FA does not provide OS or DFS benefit in patients with stage II/III CRC. Nevertheless, AREG/EREG negative, PTEN positive and Hif-1 α negative patients might profit significantly in terms of DFS from a treatment containing fluoropyrimidines and irinotecan. Our results suggest a predictive value of these biomarkers concerning adjuvant chemotherapy with 5-FU/FA +/− irinotecan in stage II/III colorectal cancer.
Background: Fatigue is a common symptom of chronic hepatitis C virus (HCV) infection and a frequent side-effect of peginterferon/ribavirin (PR) therapy for HCV. This study evaluated the impact of adding the oral HCV NS3/4A protease inhibitor simeprevir to PR on patient-reported fatigue and health status among patients with chronic HCV genotype 1 infection enrolled in the Phase IIb PILLAR and ASPIRE trials [NCT00882908; NCT00980330].
Methods: Treatment-naïve patients (PILLAR, n = 386) and treatment-experienced patients (ASPIRE, n = 462) were randomized to simeprevir plus PR (simeprevir/PR) or placebo plus PR (placebo/PR). In PILLAR, duration of PR treatment in the simeprevir/PR groups was determined using response-guided therapy (RGT) criteria. PR could be terminated at Week 24, instead of Week 48, if HCV RNA was <25 IU/mL by Week 4 and then undetectable at Weeks 12, 16, and 20. In both studies, patients completed the Fatigue Severity Scale (FSS) and EQ-5D quality-of-life questionnaire in their native language at baseline and throughout the studies up until Week 72.
Results: During the first 24 weeks of treatment, mean FSS total score was increased to a similar degree compared with baseline among patients receiving simeprevir/PR or placebo/PR in both studies indicating increased fatigue severity. Mean FSS scores returned to values comparable with baseline among patients receiving simeprevir/PR after Week 24 in PILLAR (after treatment completion for the majority of patients) and in ASPIRE (after Week 48), consistent with RGT enabling early termination of all treatment at Week 24 in 82.2% of simeprevir/PR-treated patients in the PILLAR study. Similar results were observed for EQ-5D, with simeprevir/PR-treated patients experiencing less time with worse health problems according to EQ-5D scores compared with placebo/PR groups in both studies, and more rapid improvement in health status associated with shorter treatment duration in the PILLAR study.
Conclusions: Combination of simeprevir with PR did not increase patient-reported fatigue severity or health status impairments beyond that reported by patients treated with PR alone. Many patients treated with simeprevir/PR returned to pretreatment fatigue and health status levels sooner due to increased treatment efficacy that enabled shorter duration of all therapy, compared with PR alone.
Background: Aviscumine, a recombinant plant protein, is an immune modulator that induces ribotoxic stress at the 28S ribosomal RNA subunit. In this way cytokine release and T-cell responses are enhanced. This phase II trial was conducted to test the efficacy and safety of aviscumine in patients with systemically pre-treated metastatic melanoma stage IV.
Methods: A total of 32 patients with progressive stage IV melanoma after failure of standard therapy were enrolled onto a single-arm, multi-centre, open-label, phase II trial. All patients had an ECOG performance status of 0 or 1. Patients received 350 ng aviscumine twice weekly by subcutaneous injection until progression. The primary end points were progression-free survival (PFS) and overall survival (OS). Safety was assessed as adverse events (AEs). Tumor response was assessed every eight weeks and survival of patients was followed up to one year after the end of therapy. Thirty one patients (intent-to-treat population (ITT)) were assessed for efficacy; safety was assessed in the whole population.
Results: One patient achieved a partial response (PR) and 10 patients showed stable disease/no change (SD). The median progression-free survival (mPFS) was 63 days (95% CI 57–85) and median overall survival (mOS) was 335 days (95% CI 210–604). In total 210 treatment-emergent adverse events were recorded. Grade 1 or 2 AEs occurred in 72% of patients and were mostly application-site effects such as pruritus Grade 3–4 treatment-emergent drug-related adverse events occurred in 9% of patients.
Conclusion: These results suggest that aviscumine may have a clinical impact in patients with previously treated metastatic melanoma and provide rationale for further clinical evaluation of this agent. In the light of effective new immune checkpoint blockers it might be a candidate for combinations with these agents.
Background: The federal state of Hesse, Germany, introduced a laboratory-based reporting scheme for carbapenem-resistant organisms (CROs).
Method: The results of the first year of mandated reporting of CROs from April 2012 through March 2013 to the Public Health Authority of Frankfurt/Main, responsible for a population of 700,000 inhabitants, are described.
Results: Within a period of 12 months 243 CROs were notified to the health authority. Of these 213 isolates had been reported from 16 of the 17 hospitals in Frankfurt/Main, 6 from ambulatory settings and 24 from clinics outside of Frankfurt/Main. Mean incidence rate per 1,000 patient days in hospitals was 0.138 (range 0.02-0.28).
Conclusion: In Frankfurt/Main almost all hospitals have reported CROs in the study period though the frequency of isolation varies strongly and many facilities only report CROs sporadically. Molecular data indicate a high diversity of different carbapenemases. Autochthonous transmission must be assumed despite the absence of major outbreaks. Rapid and coordinated efforts by clinicians and health departments are crucial to control the spread of CRO infections. The mandatory reporting scheme provides important data to guide the implementation of preventive measures.
Non-coding RNAs (ncRNAs) play various roles during central nervous system development. MicroRNAs (miRNAs) are a class of ncRNAs that exert their function together with argonaute proteins by post-transcriptional gene silencing of messenger RNAs (mRNAs). Several studies provide evidence for alterations in miRNA expression in patients with neurodegenerative diseases. Among these is huntington‘s disease (HD), a dominantly inherited fatal disorder characterized by deregulation of neuronal-specific mRNAs as well as miRNAs. Recently, next-generation sequencing (NGS) miRNA profiles from human HD and neurologically normal control brain tissues were reported. Five consistently upregulated miRNAs affect the expression of genes involved in neuronal differentiation, neurite outgrowth, cell death and survival. We re-analyzed the NGS data publicly available in array express and detected nineteen additional differentially expressed miRNAs. Subsequently, we connected these miRNAs to genes implicated in HD development and network analysis pointed to miRNA-mediated downregulation of twenty-two genes with roles in the pathogenesis as well as treatment of the disease. In silico prediction and reporter systems prove that levels of BDNF, a central node in the miRNA-mRNA regulatory network, can be post-transcriptionally controlled by upregulated miR-10b-5p and miR-30a-5p. Reduced BDNF expression is associated with neuronal dysfunction and death in HD. Moreover, the 3’UTR of CREB1 harbors a predicted binding site for these two miRNAs. CREB1 is similarly downregulated in HD and overexpression decreased susceptibility to 3-nitropropionic-induced toxicity in a cell model. In contradiction to these observations, it is presumed that miR-10b-5p upregulation in HD exerts a neuroprotective role in response to the mutation in the huntingtin gene. Therefore, the function of miR-10b-5p and especially its effect on BDNF expression in HD requires further academic research.
(Micro)plastics in the aquatic environment are an issue of emerging concern. However, to date, there is considerable lack of knowledge on the abundance and toxicity of plastic debris in aquatic ecosystems, especially with regard to the freshwater situation. In this editorial, we briefly discuss important aspects of the research on environmental (micro)plastics to stimulate research and call for papers.
Background: Different flavonoids are known to interfere with influenza A virus replication. Recently, we showed that the structurally similar flavonoids baicalein and biochanin A inhibit highly pathogenic avian H5N1 influenza A virus replication by different mechanisms in A549 lung cells. Here, we investigated the effects of both compounds on H5N1-induced reactive oxygen species (ROS) formation and the role of ROS formation during H5N1 replication.
Findings: Baicalein and biochanin A enhanced H5N1-induced ROS formation in A549 cells and primary human monocyte-derived macrophages. Suppression of ROS formation induced by baicalein and biochanin A using the antioxidant N-acetyl-L-cysteine strongly increased the anti-H5N1 activity of both compounds in A549 cells but not in macrophages.
Conclusions: These findings emphasise that flavonoids induce complex pharmacological actions some of which may interfere with H5N1 replication while others may support H5N1 replication. A more detailed understanding of these actions and the underlying structure-activity relationships is needed to design agents with optimised anti-H5N1 activity.
Background: Dysregulation of the autonomic nervous system is frequent in subjects with cardiovascular disease. The contribution of different forms of renovascular hypertension and the mechanisms contributing to autonomic dysfunction in hypertension are incompletely understood. Here, murine models of renovascular hypertension with preserved (2-kidneys-1 clip, 2K1C) and reduced (1-kidney-1 clip, 1K1C) kidney mass were studied with regard to autonomic nervous system regulation (sympathetic tone: power-spectral analysis of systolic blood pressure; parasympathetic tone: power-spectral analysis of heart rate) and baroreflex sensitivity of heart rate by spontaneous, concomitant changes of systolic blood pressure and pulse interval. Involvement of the renin-angiotensin system and the rho-kinase pathway were determined by application of inhibitors.
Results: C57BL6N mice (6 to 11) with reduced kidney mass (1K1C) or with preserved kidney mass (2K1C) developed a similar degree of hypertension. In comparison to control mice, both models presented with a significantly increased sympathetic tone and lower baroreflex sensitivity of heart rate. However, only 2K1C animals had a lower parasympathetic tone, whereas urinary norepinephrine excretion was reduced in the 1K1C model. Rho kinase inhibition given to a subset of 1K1C and 2K1C animals improved baroreflex sensitivity of heart rate selectively in the 1K1C model. Rho kinase inhibition had no additional effects on autonomic nervous system in either model of renovascular hypertension and did not change the blood pressure. Blockade of AT1 receptors (in 2K1C animals) normalized the sympathetic tone, decreased resting heart rate, improved baroreflex sensitivity of heart rate and parasympathetic tone.
Conclusions: Regardless of residual renal mass, blood pressure and sympathetic tone are increased, whereas baroreflex sensitivity is depressed in murine models of renovascular hypertension. Reduced norepinephrine excretion and/or degradation might contribute to sympathoactivation in renovascular hypertension with reduced renal mass (1K1C). Overall, the study helps to direct research to optimize medical therapy of hypertension.